BeOne Medicines Ltd.ONC
Market cap
$443.5B
P/E ratio
| Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
| Product | - | - | 131 | 223 | 309 | - | 1,255 | 2,190 | 3,780 |
| Collaboration revenue | - | - | 67 | 206 | - | - | 161 | 269 | 31 |
| Total revenues | - | - | 198 | 428 | 309 | - | 1,416 | 2,500 | 3,800 |
| Cost of sales - product | - | - | - | - | - | - | - | 380 | 594 |
| Gross profit | - | - | - | - | - | - | - | 2,079 | 3,216 |
| Research and development | 98 | 269 | 679 | 927 | 1,295 | 1,459 | 1,641 | 1,779 | 1,953 |
| Selling, general and administrative | - | 63 | 195 | 388 | 600 | 990 | 1,278 | 1,505 | 1,831 |
| Total operating expenses | 118 | 337 | 904 | 1,388 | 1,967 | 2,615 | 3,206 | 3,287 | 3,784 |
| Loss from operations | -117 | -98 | -706 | -960 | -1,658 | -1,439 | -1,790 | -1,208 | -568 |
| Interest income, net | - | - | - | - | - | - | - | - | 48 |
| Other (expense) income, net | 0 | 11 | 2 | 7 | 37 | 16 | -224 | 308 | -13 |
| Loss before income taxes | -119 | - | - | - | - | - | - | - | -533 |
| Income tax expense | 0 | 2 | -16 | 7 | -18 | -25 | 43 | 56 | 112 |
| Net loss | -119 | -93 | -674 | -949 | -1,597 | -1,413 | -2,004 | -882 | -645 |
| Earnings Per Share, Basic | - | - | - | - | - | -1.17 | -1.49 | -0.65 | -0.47 |
| Earnings Per Share, Diluted | - | - | - | - | - | -1.17 | -1.49 | -0.65 | -0.47 |
| Earnings Per American Depository Share, Basic | - | - | - | - | - | -15.23 | -19.43 | -8.45 | -6.12 |
| Earnings Per American Depository Share, Diluted | - | - | - | - | - | -15.23 | -19.43 | -8.45 | -6.12 |